Frank Gianfrancesco

Summary

Publications

  1. ncbi request reprint Use of healthcare services by patients treated with risperidone versus conventional antipsychotic agents
    Frank Gianfrancesco
    HECON Associates Inc, Montgomery Village, Maryland 20886, USA
    Pharmacoeconomics 20:413-27. 2002
  2. ncbi request reprint Hospitalization risks in the treatment of bipolar disorder: comparison of antipsychotic medications
    Frank Gianfrancesco
    HECON Associates, Inc, Montgomery Village, MD 20886, USA
    Bipolar Disord 9:252-61. 2007
  3. ncbi request reprint Methods for claims-based pharmacoeconomic studies in psychosis
    Frank Gianfrancesco
    HECON Associates, Inc, Montgomery Village, Maryland, USA
    Pharmacoeconomics 20:499-511. 2002
  4. ncbi request reprint Differential effects of antipsychotic agents on the risk of development of type 2 diabetes mellitus in patients with mood disorders
    Frank Gianfrancesco
    HECON Associates, Inc, Montgomery Village, Maryland 20886, USA
    Clin Ther 25:1150-71. 2003
  5. ncbi request reprint The influence of study design on the results of pharmacoepidemiologic studies of diabetes risk with antipsychotic therapy
    Frank Gianfrancesco
    HECON Associates, Inc, Montgomery Village, MD, USA
    Ann Clin Psychiatry 18:9-17. 2006
  6. ncbi request reprint Relationship between initial quetiapine dose and effectiveness as reflected in subsequent mental health service use among patients with schizophrenia or bipolar disorder
    Frank Gianfrancesco
    HECON Associates, Inc, Montgomery Village, MD 20886, USA
    Value Health 8:471-8. 2005
  7. ncbi request reprint Comparison of mental health resources used by patients with bipolar disorder treated with risperidone, olanzapine, or quetiapine
    Frank Gianfrancesco
    HECON Associates, Inc, 9833 Whetstone Dr, Montgomery Village, MD 20886, USA
    J Manag Care Pharm 11:220-30. 2005
  8. ncbi request reprint Hospitalization risks in the treatment of schizophrenia: comparison of antipsychotic medications
    Frank Gianfrancesco
    HECON Associates Inc, 9833 Whetstone Drive, Montgomery Village, MD 20886, USA
    J Clin Psychopharmacol 26:401-4. 2006
  9. ncbi request reprint Assessment of antipsychotic-related risk of diabetes mellitus in a Medicaid psychosis population: sensitivity to study design
    Frank Gianfrancesco
    HECON Associates, Inc, Montgomery Village, MD 20886, USA
    Am J Health Syst Pharm 63:431-41. 2006
  10. ncbi request reprint Antipsychotic-induced type 2 diabetes: evidence from a large health plan database
    Frank Gianfrancesco
    HECON Associates, 9833 Whetstone Drive, Montgomery Village, MD 20886, USA
    J Clin Psychopharmacol 23:328-35. 2003

Detail Information

Publications10

  1. ncbi request reprint Use of healthcare services by patients treated with risperidone versus conventional antipsychotic agents
    Frank Gianfrancesco
    HECON Associates Inc, Montgomery Village, Maryland 20886, USA
    Pharmacoeconomics 20:413-27. 2002
    ..To determine whether the use of risperidone in a US managed-care environment is associated with a reduction in the use of mental healthcare services...
  2. ncbi request reprint Hospitalization risks in the treatment of bipolar disorder: comparison of antipsychotic medications
    Frank Gianfrancesco
    HECON Associates, Inc, Montgomery Village, MD 20886, USA
    Bipolar Disord 9:252-61. 2007
    ..This study compared the relative risk for hospitalization of patients with bipolar and manic disorders receiving atypical and typical antipsychotics...
  3. ncbi request reprint Methods for claims-based pharmacoeconomic studies in psychosis
    Frank Gianfrancesco
    HECON Associates, Inc, Montgomery Village, Maryland, USA
    Pharmacoeconomics 20:499-511. 2002
    ..Determining the most appropriate methods for claims-based data involves careful evaluation of the alternate approaches to best achieve the goals of a pharmacoeconomic investigation...
  4. ncbi request reprint Differential effects of antipsychotic agents on the risk of development of type 2 diabetes mellitus in patients with mood disorders
    Frank Gianfrancesco
    HECON Associates, Inc, Montgomery Village, Maryland 20886, USA
    Clin Ther 25:1150-71. 2003
    ..Atypical antipsychotics are being used increasingly in the management of mood disorders...
  5. ncbi request reprint The influence of study design on the results of pharmacoepidemiologic studies of diabetes risk with antipsychotic therapy
    Frank Gianfrancesco
    HECON Associates, Inc, Montgomery Village, MD, USA
    Ann Clin Psychiatry 18:9-17. 2006
    ..Retrospective large patient database studies have reported conflicting findings regarding diabetes risks associated with antipsychotics. This study compared two study designs to assess antipsychotic-related diabetes risk...
  6. ncbi request reprint Relationship between initial quetiapine dose and effectiveness as reflected in subsequent mental health service use among patients with schizophrenia or bipolar disorder
    Frank Gianfrancesco
    HECON Associates, Inc, Montgomery Village, MD 20886, USA
    Value Health 8:471-8. 2005
    ..To investigate the association between initial quetiapine dose and effectiveness as gauged by subsequent use of mental health services...
  7. ncbi request reprint Comparison of mental health resources used by patients with bipolar disorder treated with risperidone, olanzapine, or quetiapine
    Frank Gianfrancesco
    HECON Associates, Inc, 9833 Whetstone Dr, Montgomery Village, MD 20886, USA
    J Manag Care Pharm 11:220-30. 2005
    ..A secondary analysis involved dose-equivalent adjustment of the average allowed charge of the 3 atypical antipsychotics...
  8. ncbi request reprint Hospitalization risks in the treatment of schizophrenia: comparison of antipsychotic medications
    Frank Gianfrancesco
    HECON Associates Inc, 9833 Whetstone Drive, Montgomery Village, MD 20886, USA
    J Clin Psychopharmacol 26:401-4. 2006
    ..40; 95% CI, 0.94-2.07). Overall, olanzapine was associated with a higher risk for hospitalization than the typical antipsychotic drugs and among the atypical antipsychotic drugs, risperidone and, potentially, quetiapine...
  9. ncbi request reprint Assessment of antipsychotic-related risk of diabetes mellitus in a Medicaid psychosis population: sensitivity to study design
    Frank Gianfrancesco
    HECON Associates, Inc, Montgomery Village, MD 20886, USA
    Am J Health Syst Pharm 63:431-41. 2006
    ..The effect of study design on findings regarding diabetes risk associated with antipsychotics was studied...
  10. ncbi request reprint Antipsychotic-induced type 2 diabetes: evidence from a large health plan database
    Frank Gianfrancesco
    HECON Associates, 9833 Whetstone Drive, Montgomery Village, MD 20886, USA
    J Clin Psychopharmacol 23:328-35. 2003
    ..This study supports earlier findings on risperidone versus olanzapine and builds evidence on quetiapine. Additional studies are needed to evaluate the association of antipsychotic treatment with type 2 diabetes...